Ropes & Gray represented Avista Capital Partners and its portfolio company United BioSource LLC (UBC), a biopharmaceutical services provider, in its acquisition of Examoto, LLC, a Risk Evaluation and Mitigation Strategy (REMS) company. Terms of the transaction were not disclosed. The deal was announced on July 28 in aĀ press release.
Examoto is a leader in FDA-mandated REMS compliance platforms addressing safer pharmaceutical outcomes. UBC provides integrated clinical, safety, and commercialization services to the biopharmaceutical market. Avista Capital Partners is a New York-based private equity firm that has invested nearly $8 billion in 40 growth-oriented healthcare businesses around the world.
The Ropes & Gray team that represented Avista Capital was led by private equity partnerĀ Bob RivollierĀ and senior associateĀ Sam Levitt, and included employment, executive compensation & benefits partnerĀ Danna Kivell,Ā health care partnerĀ Devin Cohen, FDA regulatory partnerĀ Kellie Combs, finance partnerĀ Arek Maczka, and tax partnerĀ Benjamin Rogers.
